Medtech startup Qure.ai has raised $65 Mn (INR 543 Cr) in a Series D round, co-led by Lightspeed Venture Partners and 360 ONE Asset Management. Other participants include Merck Global Health Innovation Fund and Kae Capital, along with existing investors Novo Holdings, Health Quad, and TeamFund.

Funding Usage:

• Expansion in the U.S. and other markets
• Improvement of GenAI foundation models
• Funding for potential acquisitions

The primary focus is on developing AI-based products for more efficient disease detection.

About Qure.ai: Founded in 2016 by Prashant Warier, Qure.ai utilizes AI to assist in medical imaging diagnostics. The company's technology is used to detect conditions like brain trauma and chest diseases.

• Its algorithm can quickly analyze X-rays, CT scans, and MRIs, reducing diagnostic time.

CEO’s Perspective: Prashant Warier, cofounder and CEO of Qure.ai, told Bloomberg that AI is helping overcome healthcare bottlenecks. It is increasingly used in:

• Drug discovery
• Patient management in hospitals
• Surgical robotics

India's Medtech Landscape: India’s medtech industry is undergoing a transformation, driven by:

• Digital health adoption
• AI integration
• Growth of wearable technology

AI is revolutionizing medical diagnostics and treatment, with substantial investments from startups and large companies alike.

Source: Inc42